Sterneck Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CORR.PRA
CorEnergy Infrastructure Trust, Inc Depositary Shares representing a 1/100th fractional interest of a share of 7.375% Series A Cumulative Redeemable Preferred Stock
CORR.PRA
|
+$2.46M |
| 2 |
CBI
Chicago Bridge & Iron Nv
CBI
|
+$1.95M |
| 3 |
AHRT
AH Realty Trust
AHRT
|
+$1.63M |
| 4 |
Omega Healthcare
OHI
|
+$1.62M |
| 5 |
IBM
IBM
|
+$1.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$3.22M |
| 2 |
FPF
First Trust Intermediate Duration Preferred & Income Fund
FPF
|
+$2.5M |
| 3 |
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
|
+$1.89M |
| 4 |
Abbott
ABT
|
+$1.1M |
| 5 |
ODP
ODP
ODP
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 15.69% |
| 2 | Technology | 15.29% |
| 3 | Financials | 12.63% |
| 4 | Healthcare | 8.78% |
| 5 | Consumer Discretionary | 7.02% |
Similar funds
Sterneck Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Sterneck Capital Management held 130 positions worth $167M, down 0.64% from $168M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Sterneck Capital Management's Q2 2017 filing shows 10 new, 40 increased, 36 reduced and 16 closed positions. Its largest new stake was CorEnergy Infrastructure Trust, Inc Depositary Shares representing a 1/100th fractional interest of a share of 7.375% Series A Cumulative Redeemable Preferred Stock: 98,458 shares worth $2.46M. The largest sale was GSK, an estimated $3.22M.
By sector, the portfolio is most concentrated in Communication Services at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Sterneck Capital Management's largest Q2 2017 buy was CorEnergy Infrastructure Trust, Inc Depositary Shares representing a 1/100th fractional interest of a share of 7.375% Series A Cumulative Redeemable Preferred Stock: 98,458 shares worth $2.46M.
- Sterneck Capital Management added most to Omega Healthcare in Q2 2017, an estimated $1.62M increase.
- Sterneck Capital Management's biggest Q2 2017 reduction was GSK, cutting an estimated $3.22M.
- Sterneck Capital Management fully exited OAKTREE CAPITAL GROUP, LLC in Q2 2017, selling an estimated $1.89M.
- Sterneck Capital Management's ten largest holdings make up 30% of its $167M portfolio in Q2 2017.
- Sterneck Capital Management opened 10 new positions and closed 16 in Q2 2017.
- Sterneck Capital Management's portfolio value fell 0.64% quarter-over-quarter to $167M.
Based on Sterneck Capital Management's 13F filing for Q2 2017, filed 16 Aug 2017.